121 related articles for article (PubMed ID: 21361708)
1. Tissue responses to hexyl 5-aminolevulinate-induced photodynamic treatment in syngeneic orthotopic rat bladder cancer model: possible pathways of action.
Arum CJ; Gederaas OA; Larsen EL; Randeberg LL; Hjelde A; Krokan HE; Svaasand LO; Chen D; Zhao CM
J Biomed Opt; 2011 Feb; 16(2):028001. PubMed ID: 21361708
[TBL] [Abstract][Full Text] [Related]
2. Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate.
Berrahmoune S; Fotinos N; Bezdetnaya L; Lange N; Guedenet JC; Guillemin F; D'Hallewin MA
Photochem Photobiol Sci; 2008 Sep; 7(9):1018-24. PubMed ID: 18754047
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladder cancer by optical spectroscopy.
Larsen EL; Randeberg LL; Gederaas OA; Arum CJ; Hjelde A; Zhao CM; Chen D; Krokan HE; Svaasand LO
J Biomed Opt; 2008; 13(4):044031. PubMed ID: 19021358
[TBL] [Abstract][Full Text] [Related]
4. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
[TBL] [Abstract][Full Text] [Related]
5. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model.
Berndt-Paetz M; Schulze P; Stenglein PC; Weimann A; Wang Q; Horn LC; Riyad YM; Griebel J; Hermann R; Glasow A; Stolzenburg JU; Neuhaus J
Mol Cancer Ther; 2019 Apr; 18(4):743-750. PubMed ID: 30824608
[TBL] [Abstract][Full Text] [Related]
7. How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate.
François A; Salvadori A; Bressenot A; Bezdetnaya L; Guillemin F; D'Hallewin MA
J Urol; 2013 Aug; 190(2):731-6. PubMed ID: 23353049
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with hexyl aminolevulinate induces carbonylation, posttranslational modifications and changed expression of proteins in cell survival and cell death pathways.
Baglo Y; Sousa MM; Slupphaug G; Hagen L; Håvåg S; Helander L; Zub KA; Krokan HE; Gederaas OA
Photochem Photobiol Sci; 2011 Jul; 10(7):1137-45. PubMed ID: 21448498
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder.
Vandepitte J; Van Cleynenbreugel B; Hettinger K; Van Poppel H; de Witte PA
Cancer Chemother Pharmacol; 2011 Apr; 67(4):775-81. PubMed ID: 20532886
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).
Bader MJ; Stepp H; Beyer W; Pongratz T; Sroka R; Kriegmair M; Zaak D; Welschof M; Tilki D; Stief CG; Waidelich R
Urol Oncol; 2013 Oct; 31(7):1178-83. PubMed ID: 22440147
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic treatment with hexyl-aminolevulinate mediates reversible thiol oxidation in core oxidative stress signaling proteins.
Helander L; Sharma A; Krokan HE; Plaetzer K; Krammer B; Tortik N; Gederaas OA; Slupphaug G; Hagen L
Mol Biosyst; 2016 Mar; 12(3):796-805. PubMed ID: 26742548
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
15. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model.
El Khatib S; Didelon J; Leroux A; Bezdetnaya L; Notter D; D'Hallewin M
J Urol; 2004 Nov; 172(5 Pt 1):2013-7. PubMed ID: 15540780
[TBL] [Abstract][Full Text] [Related]
16. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells.
Furre IE; Shahzidi S; Luksiene Z; Møller MT; Borgen E; Morgan J; Tkacz-Stachowska K; Nesland JM; Peng Q
Cancer Res; 2005 Dec; 65(23):11051-60. PubMed ID: 16322255
[TBL] [Abstract][Full Text] [Related]
17. Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach.
Vaucher L; Jichlinski P; Lange N; Ritter-Schenk C; van den Bergh H; Kucera P
Lasers Surg Med; 2007 Jan; 39(1):67-75. PubMed ID: 17096415
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with the novel photosensitizer chlorophyllin f induces apoptosis and autophagy in human bladder cancer cells.
Lihuan D; Jingcun Z; Ning J; Guozeng W; Yiwei C; Wei L; Jing Q; Yuanfang Z; Gang C
Lasers Surg Med; 2014 Apr; 46(4):319-34. PubMed ID: 24464873
[TBL] [Abstract][Full Text] [Related]
19. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
20. Modulation of telomerase and signal transduction proteins by hexyl-ALA-photodynamic therapy (PDT) in human doxorubicin resistant cancer cell models.
Chu ES; Yow CM
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):243-55. PubMed ID: 22959804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]